Abstract
Randomised controlled trials (RCTs) in the 1970s and early 1980s showed the polysaccharide serogroup A vaccine (SgAV) prevented serogroup A meningococcal meningitis (SGAMM). Subsequent non-RCTs suggested significant variations in the age-specific duration of protection among children.
| Original language | English |
|---|---|
| Pages (from-to) | 1-32pp |
| Journal | Cochrane Database of Systematic Reviews (CDSR) |
| Volume | May 26, 2010 |
| Publication status | Published - 2010 |